Government Policy

FDA Commissioner Calls on Internet Providers to Help Police Opioid Offerings

April 5, 2018

The head of the Food and Drug Administration on Wednesday called on Internet providers to help rid the Web of illegal offers of prescription opioids and illicit drugs such as fentanyl that have contributed to the nation’s drug crisis. And on Thursday, the surgeon general is scheduled to recommend that more people keep on hand […]

House Approves ‘Right-To-Try’ Bill, Sending Legislation To Senate

March 22, 2018

WASHINGTON — House Republicans easily passed a controversial bill aimed at helping some dying patients get new access to experimental therapies Wednesday, resurrecting legislation that suffered a major setback just a week ago.   Passage of the bill, on a largely party-line vote of 267-149, is a step forward for the “right-to-try” movement, after House […]

Pricing system reform and generics trend apparent at CPhI Japan 2018

March 19, 2018

Bio and generic demand reflective of wider trends in the market – with overseas investments now prospering Amsterdam, 19 March 2018: Increased international generic API companies and suppliers are reported at next month’s CPhI Japan 2018, traditionally an innovative drug focussed market, due to recent changes in the country. As uncovered earlier this year in the CPhI Japan 2018 report, […]

House Rejects Bill to Give Patients a ‘Right to Try’ Experimental Drugs

March 15, 2018

WASHINGTON — In a surprising rebuff to President Trump and Republican leaders, the House derailed a bill on Tuesday that would have given patients with terminal illnesses a right to try unproven experimental treatments. The bill was considered under special fast-track procedures that required a two-thirds majority for passage, and it fell short. When the […]

The California Co-Pay Conundrum

January 2, 2018

TrialCard Addresses AB 265 On October 9, 2017, California Governor Jerry Brown signed AB 265 into law. This landmark piece of legislation modified the California Health and Safety Code to prohibit the “offering” of any discount, product voucher, or other out-of-pocket cost reduction tool by drug manufacturers when there is an FDA-approved therapeutic equivalent. As […]

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing

November 27, 2017

Symcel: 21 November 2017: Symcel, the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, calScreener™, has secured €3.572 million Horizon 2020 funding to support the company’s evaluation of improved combination testing of antibiotics against extensively drug-resistant bacteria in sepsis patients. The project runs over 28 months with a consortium of internationally recognized […]

US Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics

November 13, 2017

–-PGDx’s Pan-Cancer Profiling Panels with MSI Testing for Immuno-Oncology Applications Are Now Available Nationwide to Cancer Patients Treated at the VA–                                                                                                   –PGDx’s CancerSELECTTM 125 Offers Comprehensive Tissue-Based Tumor Profiling and Its PlasmaSELECTTM 64 Is First Liquid Biopsy Assay Available to Patients at VA Facilities— BALTIMORE, MD –Personal Genome Diagnostics Inc. (PGDx) today announced the renewal […]

New Peer-Reviewed Study Finds Illegal Online Pharmacies are Using Twitter to Illegally Sell Percocet®, Fentanyl, Vicodin®, Oxycotin®, and Other Highly Addictive Opiods To U.S. Consumers

October 26, 2017

SAN DIEGO, CA (October 26, 2017) – Results from a new peer-reviewed study to be published in the November issue of American Journal of Public Health (AJPH) found illegal online pharmacies are using Twitter to market and sell Percocet®, Vicodin®, Oxycontin®, hydrocodone, fentanyl and oxycodone and other highly addictive and often deadly controlled substances to U.S. consumers, […]

India’s generics exports expanding 22% per year

October 24, 2017

Country accounts for over 20% of global production with $20 billion exports forecast by 2020 24th October 2017, Frankfurt: The India Brand Equity foundation (IBEF) and the Pharmaceuticals Export Promotion Council (PHARMEXCIL) provide an update on the country’s generics market as the world’s pharma industry meets for its annual exposition at CPhI Worldview in Frankfurt. Data confirms that […]

Science Exchange to Host Webinar on How to Prepare for EU General Data Protection Regulation (GDPR)

October 3, 2017

PALO ALTO, CA, SEPTEMBER 27, 2017 – Science Exchange, the world’s leading and most secure platform for outsourced research and development (R&D), announced today that it will host a webinar titled, “Are You Ready? Preparing for EU Data Protection Regulation.” At this free, online event on Tuesday, October 3, at 11:00 am ET, Science Exchange […]

APPCON India – ASIAN Pharma Packaging Conference

August 21, 2017

APPCON India – ASIAN Pharma Packaging Conference Location: Mumbai-India Dates: 2nd & 3rdNovember 2017 For Agenda/Event Brochure, Information & Registration, Contact: Priyesh Waghmare E: | T: +91 (0)20.6527.2803 Quote discount code: PPCi1MP20 to claim for 20% discount expiring 7th September 2017 & PPCi1MP15 to claim for 15% discount expiring 19th October 2017 The objective of the conference is to secure and optimize packaging by navigating […]

CR Expo China 2017 Poised to Boost Rise of Assistive Device Industry

August 21, 2017

The press conference for Care & Rehabilitation Expo China 2017 was held at China Disabled Persons’ Federation, on August 14th, 2017. Present at the conference are leaders including HU Xiangyang, Director of Rehabilitation Department of China Disabled Persons’ Federation, LI Xi, Director of China Assistive Devices and Technology Centre for Persons with Disabilities, OU Ling, […]

China FDA, US FDA and industry leaders collaborated with great success during Marketing Authorization Holder system summit

July 18, 2017

Discussions at the MAH symposium showed a positive outlook with the pilot program and calls for the marketing authorization system to be adopted nationwide. STA Pharmaceutical Co., Ltd. (STA)  – a WuXi AppTec subsidiary and a leading open-access capability and technology platform for small molecule pharmaceutical development and manufacturing – co-organized a summit along with […]